Shennon Biotechnologies Shennon Biotechnologies is a company that develops a single-cell platform to provide treatments for human diseases. | Nexmos Nexmos is a company engaged in the development of aptamer-based technology in a variety of applications. | ||
Founding Date | Founding Date 2015 | Founding Date 2021 | Founding Date 2014 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Richmond, US HQ | Locations San Francisco, US HQ | Locations 용인시, KR HQ |
Employees | Employees 60 | Employees 13 | Employees 4 |
Funding | |||
Total funding raised | Total funding raised $ 123.9m | Total funding raised $ 13m | Total funding raised N/A |
Shennon Biotechnologies is a company that develops a single-cell platform to provide treatments for human diseases.
View companyNexmos is a company engaged in the development of aptamer-based technology in a variety of applications.
View company